EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Investigation of vaccine reactions and breakdowns after feline calicivirus vaccination


, : Investigation of vaccine reactions and breakdowns after feline calicivirus vaccination. Veterinary Record 132(14): 346-350

The clinical and epidemiological features of feline calicivirus associated vaccine reactions and breakdowns were investigated. 20% of 123 vaccine reactions were associated with acute oral/respiratory disease alone, and 80% were associated with lameness either alone or in association with other clinical signs.


Accession: 002416968

PMID: 8387712

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Jas, D.; Aeberlé, C.; Lacombe, V.; Guiot, A.L.; Poulet, H., 2008: Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus. The induction of a quick onset of immunity against feline parvovirus (FPV), feline herpesvirus (FHV) and feline calicivirus (FCV) is critical both in young kittens after the decline of maternal antibodies and in cats at high risk of exposure. The...

Gaskell C.J.; Gaskell R.M.; Dennis P.E.; Wooldridge M.J.A., 1982: Efficacy of an inactivated feline calicivirus vaccine against challenge with uk field strains and its interaction with the feline calicivirus carrier state. The efficacy of an inactivated vaccine derived from feline calicivirus (FCV) strain FS2 was assessed against challenge with 3 UK field strains of FCV. The mean clinical score, calculated on the number of signs recorded per day over 21 days after c...

Huang, C.; Hess, J.; Gill, M.; Hustead, D., 2010: A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease. Feline calicivirus (FCV) causes an array of clinical disease in cats. Traditionally this disease has been associated with respiratory disease, limping, or chronic stomatitis. Within the last 10 years, virulent systemic feline calicivirus (VS-FCV)...

Bittle, J.L.; Rubic, W.J., 1975: A feline calicivirus vaccine combined with feline viral rhinotracheitis and feline panleukopenia vaccine. A feline calicivirus vaccine prepared from strain F-9 gave satisfactory results in both serological and challenge tests on vaccinated cats, whether used alone or combined with one or both other vaccines. No adverse clinical reactions were observed...

Lappin, M.R., 2012: Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine. Two groups of feline panleukopenia (FPV), feline calicivirus (FCV) and feline herpesvirus 1 (FHV-1) seronegative kittens (six cats per group) were administered one of two feline viral rhinotracheitis, calcivirus and panleukopenia (FVRCP) vaccines...

Dawson, S.; Willoughby, K.; Gaskell, R.M.; Wood, G.; Chalmers, W.S., 2001: A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens. A trivalent (feline panleukopenia, feline herpesvirus, feline calicivirus), modified live, commercially available cat vaccine was used at either 6, 9 and 12 weeks of age (early schedule), or 9 and 12 weeks of age (conventional schedule), and the s...

Radford, A.D.; Bennett, M.; McArdle, F.; Dawson, S.; Turner, P.C.; Glenn, M.A.; Gaskell, R.M., 1997: The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures. A reverse transcriptase polymerase chain reaction (PCR) was used to amplify a 235 bp hypervariable region of the feline calicivirus (FCV) genome which encodes part of the capsid protein. Sequence from this region was used to compare viruses used i...

Radford, A.D.; Bennett, M.; McArdle, F.; Dawson, S.; Turner, P.C.; Glenn, M.A.; Gaskell, R.M., 1997: The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures. A reverse transcriptase polymerase chain reaction (PCR) was used to amplify a 235 bp hypervariable region of the feline calicivirus (FCV) genome which encodes part of the capsid protein. Sequence from this region was used to compare viruses used i...

Gore, T.C.; Lakshmanan, N.; Williams, J.R.; Jirjis, F.F.; Chester, S.Theodore.; Duncan, K.L.; Coyne, M.J.; Lum, M.A.; Sterner, F.J., 2006: Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus. Forty-two seronegative cats received an initial vaccination at 8 weeks of age and a booster vaccination at 12 weeks. All cats were kept in strict isolation for 3 years after the second vaccination and then were challenged with feline calicivirus (...

Brunnthaler, F.J.nes-Baade, R.S.rehl, W., 1979: Results obtained in practice with vaccination to control feline viral rhinotracheitis and feline calicivirus infections. Kleintier Praxis 23(6): 273-274